Urohealth buys Microsurge in stock swap:
This article was originally published in Clinica
Executive Summary
Urohealth Systems has purchased Microsurge for $29 million in stock and the assumption of $9 million of debt. Microsurge manufactures multi-use instruments for minimally-invasive procedures such as laparoscopy and thoracoscopy. Microsurge is already on the market with two product lines, DetachaTip scissors, graspers and dissectors, and DetachaPort trocars.